Alu-Repeat Polymorphism in the Gene Coding for Tissue-Type Plasminogen Activator and the Risk of Hypertension in a Chinese Han Population.

Bing Wang, Xin Zhou, Aiming Dang, Guozhang Liu, Ran HeHypertension 2002 · DOI

Abstract

Accumulating data support an association between hypertension and impaired fibrinolytic potential abnormalities in endogenous fibrinolysis. The present study examined whether there was an association between essential hypertension and either a polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) or the plasma concentration of t-PA antigen. Chinese hypertensive subjects (n = 126) and normotensive controls (n = 102; sex- and age-matched) were recruited from outpatients of FuWai Hospital. The distributions of the II, ID, and DD genotypes of the t-PA gene in hypertensive patients (0.15, 0.49, 0.36) were similar to those in control subjects (0.11, 0.51, 0.38; p = 0.626). No significant difference in overall allele frequencies was found between the groups (p = 0.656). There was also no evidence of an association between the level of t-PA antigen and risk of hypertension. Thus, in this case-control study, neither the presence of the insertion allele of the Alu-repeat polymorphism nor the level of t-PA antigen were associated with the risk of essential hypertension in this population.

Introduction

Hypertension is a primary risk factor for cardiovascular disease, often characterized by an impaired ability to dissolve blood clots, known as fibrinolytic potential. A central enzyme in this process is tissue-type plasminogen activator (t-PA), which initiates the breakdown of fibrin.

Research has identified a common genetic variation in the t-PA gene: an Alu-repeat insertion (I) or deletion (D) of 311 base pairs in Intron 8. While studies in Western populations have suggested these genotypes might influence circulating t-PA levels, findings regarding their link to hypertension have been inconsistent. This study aims to clarify whether this genetic marker or plasma t-PA antigen levels are associated with essential hypertension in the Chinese Han population.

Methods and Materials

The study involved 126 Chinese Han outpatients with mild to moderate primary hypertension and 102 normotensive controls, matched for age and sex. Individuals with secondary hypertension, diabetes, or significant organ dysfunction were excluded.

Genotyping and Protein Analysis

DNA was extracted from blood samples, and Polymerase Chain Reaction (PCR) was used to identify the II, ID, and DD genotypes. To ensure accuracy, samples initially identified as DD (homozygous deletion) underwent a second, independent PCR using an insertion-specific primer to prevent misclassification of ID (heterozygous) samples.

PCR analysis of the Alu-repeat polymorphism in the t-PA gene showing the 966bp (Insertion) and 655bp (Deletion) bands.

Plasma levels of the t-PA antigen were measured using an Enzyme-Linked Immunosorbent Assay (ELISA). Statistical comparisons were performed using Chi-square tests for allele frequencies and ANOVA for clinical data.

Results

Genotype and Allele Distribution

The distribution of genotypes was remarkably similar between the hypertensive and normotensive groups. The frequency of the "I" allele in this Chinese Han cohort was approximately 0.36–0.40, which aligns with previous data for East Asian populations but differs significantly from African or European frequencies.

Genotype and allele frequencies of the t-PA gene in hypertensive and normotensive subjects, showing no significant statistical difference.

Statistical analysis confirmed that neither the genotype distribution (p = 0.626) nor the allele frequencies (p = 0.656) showed a significant association with hypertension. Furthermore, odds ratio analysis for various genetic models (dominant, recessive, or additive) failed to show any increased risk associated with the "I" or "D" alleles.

Clinical and Protein Correlations

While hypertensive patients exhibited higher BMI, blood pressure, and lipid levels compared to controls, these clinical risk factors did not correlate with specific t-PA genotypes. Plasma t-PA antigen levels were also statistically indistinguishable between the two groups (2.01 ng/ml in hypertensives vs. 1.95 ng/ml in controls).

Discussion

The findings suggest that the Alu-repeat polymorphism in the t-PA gene is not a primary driver of hypertension risk in the Chinese Han population. The lack of association between basal t-PA antigen levels and hypertension may be due to the complex nature of t-PA regulation; t-PA often binds to its inhibitor, PAI-1, and circulating levels may reflect the clearance rate of these complexes rather than the actual secretion rate from the endothelium.

Future research should consider measuring the dynamic vascular release rate of t-PA in response to stimuli, which may provide a more sensitive measure of fibrinolytic health than static basal levels. Additionally, exploring gene-gene interactions, particularly between t-PA and PAI-1, may yield further insights into the genetic architecture of hypertension.

Summary updated

Abstract

Accumulating data support an association between hypertension and impaired fibrinolytic potential abnormalities in endogenous fibrinolysis. The present study examined whether there was an association between essential hypertension and either a polymorphism in the gene coding for t-PA or the plasma concentration of t-PA antigen. Chinese hypertensive subjects (n = 126) and normotensive controls (n = 102; sex- and age-matched with hypertensives) were recruited from among the outpatients of FuWai Hospital. The distributions of the II, ID, and DD genotypes of the t-PA gene in hypertensive patients (0.15, 0.49, 0.36) were similar to those in control subjects (0.11, 0.51, 0.38; p = 0.626). No significant difference in overall allele frequencies was found between the hypertension and control groups (p = 0.656). The allelic frequencies were in Hardy-Weinberg equilibrium. There was no evidence of an association between the level of t-PA antigen and risk of hypertension. Thus, in this case control study, neither the presence of the insertion allele of the Alu-repeat polymorphism of the t-PA nor the level of t-PA antigen were associated with the risk of essential hypertension.
BibTeX
@inproceedings{wang2002alu,
  author = {Bing Wang and Xin Zhou and Aiming DANG and Guozhang Liu and Ran He},
  title = {{Alu-Repeat Polymorphism in the Gene Coding for Tissue-Type Plasminogen Activator and the Risk of Hypertension in a Chinese Han Population.}},
  booktitle = {Hypertension},
  year = {2002},
  doi = {10.1291/hypres.25.949},
}
Figure